Tsao Lab

Rashid S, Usoltsev D, Gupta S, Artomov M, Tsao H

Mendelian randomization analysis provides insights into the relationship between inflammatory bowel disease and skin cancer.
Mol Clin Oncol. 2025;23(3):83 - PMID: 40718635 - PMCID: PMC12290388 - DOI: 10.3892/mco.2025.2878

Latoni DI, Kim SH, Tsao H

Systemic Therapies for Metastatic Melanoma.
Dermatol Clin. 2025;43(3):483-494 - PMID: 40581428 - DOI: 10.1016/j.det.2025.03.004

Kim SH, Tsao H

Acral Melanoma: A Review of Its Pathogenesis, Progression, and Management.
Biomolecules. 2025;15(1):ePub - PMID: 39858514 - PMCID: PMC11763010 - DOI: 10.3390/biom15010120

Poudel K, Vithiananthan T, Kim JO, Tsao H

Recent progress in cancer vaccines and nanovaccines.
Biomaterials. 2024;314:122856 - PMID: 39366184 - DOI: 10.1016/j.biomaterials.2024.122856

Latoni DI, McDaniel DC, Tsao H, Tsao SS

Update on the Pathogenesis of Keloid Formation.
JID Innov. 2024;4(6):100299 - PMID: 39247523 - PMCID: PMC11378114 - DOI: 10.1016/j.xjidi.2024.100299

Everdell E, Borok J, Deutsch A, Ren Z, Cohen JV, Molina G, Vangala S, McDaniel D, Tsao H

ATLAS: A positive, high-yield review of patient symptoms most significantly associated with melanoma recurrence.
J Am Acad Dermatol. 2024;91(6):1118-1124 - PMID: 39197498 - DOI: 10.1016/j.jaad.2024.07.1516

Latoni DI, Semenov YR, Tsao H

Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapies.
J Am Acad Dermatol. 2024;91(5):872-879 - PMID: 39038555 - PMCID: PMC11653201 - DOI: 10.1016/j.jaad.2024.07.1457

Poudel K, Ji Z, Njauw CN, Rajadurai A, Bhayana B, Sullivan RJ, Kim JO, Tsao H

Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against Kit K641E -mutant melanoma.
Bioact Mater. 2024;46:347-364 - PMID: 39834347 - PMCID: PMC11742834 - DOI: 10.1016/j.bioactmat.2024.12.023

Usoltsev D, Njauw CN, Ji Z, Kumar R, Sergushichev A, Zhang S, Shlyakhto E, Daly MJ, Artomov M, Tsao H

Analysis of Variants Induced by Combined Ex Vivo Irradiation and In Vivo Tumorigenesis Suggests a Role for the ZNF831 p.R1393Q Variant in Cutaneous Melanoma Development.
J Invest Dermatol. 2024;145(7):1728-1739.e7 - PMID: 39675662 - DOI: 10.1016/j.jid.2024.08.042

Gupta S, Shaughnessy M, Rashid S, Stagner AM, Fewkes J, Marghoob AA, Tsao H

Lentigo Maligna Part II: Management.
J Am Acad Dermatol. 2024;:ePub - PMID: 39447752 - DOI: 10.1016/j.jaad.2024.07.1534

Gupta S, Shaughnessy M, Rashid S, Stagner AM, Fewkes J, Marghoob AA, Tsao H

Lentigo Maligna Part I: Epidemiology, Risk Factors, and Diagnosis.
J Am Acad Dermatol. 2024;:ePub - PMID: 39442885 - DOI: 10.1016/j.jaad.2024.09.065

Everdell E, Ji Z, Njauw CN, Tsao H

Molecular Analysis of Murine KitK641E Melanoma Progression.
JID Innov. 2024;4(3):100266 - PMID: 38585193 - PMCID: PMC10995915 - DOI: 10.1016/j.xjidi.2024.100266

Latoni DI, Foreman RK, Lavigne K, Busam KJ, Tsao H

Multiple de novo spitzoid nevi arising within a specific red tattoo ink.
JAAD Case Rep. 2024;46:78-80 - PMID: 38577501 - PMCID: PMC10992272 - DOI: 10.1016/j.jdcr.2024.02.012

Funchain P, Ni Y, Heald B, Bungo B, Arbesman M, Behera TR, McCormick S, Song JM, Kennedy LB, Nielsen SM, Esplin ED, Nizialek E, Ko J, Diaz-Montero CM, Gastman B, Stratigos AJ, Artomov M, Tsao H, Arbesman J

Germline cancer susceptibility in individuals with melanoma.
J Am Acad Dermatol. 2024;91(2):265-272 - PMID: 38513832 - DOI: 10.1016/j.jaad.2023.11.070

Latoni DI, Geller AC, Semenov YR, Ji Z, Tsao H

Geotemporal Analysis of Melanoma Incidence and Mortality Identifies Distinct Clusters of Trends within the United States Between 2001 and 2019.
J Invest Dermatol. 2024;145(2):393-399.e1 - PMID: 38981567 - PMCID: PMC11704087 - DOI: 10.1016/j.jid.2024.05.032

Win TS, Tsao H

Keratinocytic skin cancers-Update on the molecular biology.
Cancer. 2023;129(6):836-844 - PMID: 36645692 - DOI: 10.1002/cncr.34635

Tsao H, Tang C, Trembath M, Jones P, Snelling PJ

Ultrasound-guided supraclavicular block versus Bier block for emergency reduction of upper limb injuries: a protocol for an open-label, non-inferiority, randomised controlled trial.
Trials. 2023;24(1):366 - PMID: 37254224 - PMCID: PMC10230709 - DOI: 10.1186/s13063-023-07403-z

Everdell E, Denize T, Tsao H

Acquired brachial cutaneous dyschromatosis.
JAAD Case Rep. 2023;37:110-113 - PMID: 37396486 - PMCID: PMC10314224 - DOI: 10.1016/j.jdcr.2023.05.007

Wan G, Leung BW, DeSimone MS, Nguyen N, Rajeh A, Collier MR, Rashdan H, Roster K, Zhou X, Moseley CB, Nirmal AJ, Pelletier RJ, Maliga Z, Marko-Varga G, Németh IB, Tsao H, Asgari MM, Gusev A, Stagner AM, Lian CG, Hurlbert MS, Liu F, Yu KH, Sorger PK, Semenov YR

Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma.
J Am Acad Dermatol. 2023;90(2):288-298 - PMID: 37797836 - PMCID: PMC10843255 - DOI: 10.1016/j.jaad.2023.08.105

Rashid S, Molotkov I, Klebanov N, Shaughnessy M, Daly MJ, Artomov M, Tsao H

Mendelian Randomization Analysis reveals Inverse Genetic Risks between Skin Cancers and Vitiligo.
JID Innov. 2023;3(6):100217 - PMID: 38034848 - PMCID: PMC10685305 - DOI: 10.1016/j.xjidi.2023.100217

Sanna A, Phung B, Mitra S, Lauss M, Choi J, Zhang T, Njauw CN, Cordero E, Harbst K, Rosengren F, Cabrita R, Johansson I, Isaksson K, Ingvar C, Carneiro A, Brown K, Tsao H, Andersson M, Pietras K, Jönsson G

DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype.
JCI Insight. 2022;7(19):ePub - PMID: 36040798 - PMCID: PMC9675437 - DOI: 10.1172/jci.insight.156577

Rashid S, Gupta S, McCormick SR, Tsao H

New Insights into Melanoma Tumor Syndromes.
JID Innov. 2022;2(6):100152 - PMID: 36387771 - PMCID: PMC9641259 - DOI: 10.1016/j.xjidi.2022.100152

Jobbagy S, Chaudet KM, Gayhart M, Klepeis VE, Boland G, Tsao H, Duncan LM

Resilience of melanoma diagnostics at a tertiary-care hospital during the SARS-CoV-2 pandemic.
JAAD Int. 2022;9:78-79 - PMID: 36061239 - PMCID: PMC9428333 - DOI: 10.1016/j.jdin.2022.08.012

Rashid S, Shaughnessy M, Tsao H

Melanoma classification and management in the era of molecular medicine.
Dermatol Clin. 2022;41(1):49-63 - PMID: 36410983 - DOI: 10.1016/j.det.2022.07.017

Kang Y, Ji Z, Li H, Tsao H

Divergent BRAF Inhibitor Resistance Mechanisms Revealed through Epigenetic Mapping.
J Invest Dermatol. 2022;143(5):842-853.e6 - PMID: 36529262 - DOI: 10.1016/j.jid.2022.03.039

Rashid S, Tsao H

Recognition, Staging, and Management of Melanoma.
Med Clin North Am. 2021;105(4):643-661 - PMID: 34059243 - DOI: 10.1016/j.mcna.2021.04.005

Rashid S, Tsao H

Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services.
Dermatol Clin. 2021;39(4):627-637 - PMID: 34556252 - PMCID: PMC8162820 - DOI: 10.1016/j.det.2021.05.015

Guhan SM, Shaughnessy M, Rajadurai A, Taylor M, Kumar R, Ji Z, Rashid S, Flaherty K, Tsao H

The Molecular Context of Vulnerability for CDK9 Suppression in Triple Wild-Type Melanoma.
J Invest Dermatol. 2021;141(8):2018-2027.e4 - PMID: 33745909 - PMCID: PMC8316294 - DOI: 10.1016/j.jid.2020.12.035

Coroiu A, Moran C, Davine JA, Brophy K, Bergeron C, Tsao H, Körner A, Swetter SM, Geller AC

Patient-identified early clinical warning signs of nodular melanoma: a qualitative study.
BMC Cancer. 2021;21(1):371 - PMID: 33827477 - PMCID: PMC8028760 - DOI: 10.1186/s12885-021-08072-4

Atkins MB, Curiel-Lewandrowski C, Fisher DE, Swetter SM, Tsao H, Aguirre-Ghiso JA, Soengas MS, Weeraratna AT, Flaherty KT, Herlyn M, Sosman JA, Tawbi HA, Pavlick AC, Cassidy PB, Chandra S, Chapman PB, Daud A, Eroglu Z, Ferris LK, Fox BA, Gershenwald JE, Gibney GT, Grossman D, Hanks BA, Hanniford D, Hernando E, Jeter JM, Johnson DB, Khleif SN, Kirkwood JM, Leachman SA, Mays D, Nelson KC, Sondak VK, Sullivan RJ, Merlino G, Melanoma Research Foundation

The State of Melanoma: Emergent Challenges and Opportunities.
Clin Cancer Res. 2021;27(10):2678-2697 - PMID: 33414132 - PMCID: PMC8127340 - DOI: 10.1158/1078-0432.CCR-20-4092

Njauw CN, Ji Z, Pham DM, Simoneau A, Kumar R, Flaherty KT, Zou L, Tsao H

Oncogenic KIT Induces Replication Stress and Confers Cell Cycle Checkpoint Vulnerability in Melanoma.
J Invest Dermatol. 2021;142(5):1413-1424.e6 - PMID: 34687746 - DOI: 10.1016/j.jid.2021.07.188

Ji Z, Njauw CN, Guhan S, Kumar R, Reddy B, Rajadurai A, Flaherty K, Tsao H

Loss of ACK1 Upregulates EGFR and Mediates Resistance to BRAF Inhibition.
J Invest Dermatol. 2020;141(5):1317-1324.e1 - PMID: 33159968 - DOI: 10.1016/j.jid.2020.06.041

Guhan S, Boland G, Tanabe K, Lin W, Reddy B, Hawryluk EB, Sober AJ, Tsao H

Surgical delay and mortality for primary cutaneous melanoma.
J Am Acad Dermatol. 2020;84(4):1089-1091 - PMID: 32711092 - PMCID: PMC7375294 - DOI: 10.1016/j.jaad.2020.07.078

Beaulieu D, Tsao H, Michaud DS, Okhovat JP, Halpern AC, Lundberg M, Geller AC

A geographically based cross-sectional analysis of SPOT me skin cancer screening data.
J Am Acad Dermatol. 2020;84(3):809-810.e3 - PMID: 32534079 - PMCID: PMC9469797 - DOI: 10.1016/j.jaad.2020.06.014

Wang H, Osseiran S, Igras V, Nichols AJ, Roider EM, Pruessner J, Tsao H, Fisher DE, Evans CL

In vivo coherent Raman imaging of the melanomagenesis-associated pigment pheomelanin.
Sci Rep. 2016;6:37986 - PMID: 27892516 - PMCID: PMC5125099 - DOI: 10.1038/srep37986
35